Cellectricon
Cellectricon collaborates with SCiSOURCE to build on successful
expansion in the North American Life Science market
Gothenburg, Sweden, February 27, 2010: Cellectricon, a leading provider of
screening solutions for drug discovery and research, today announced an
agreement with SCiSOURCE LLC. To respond to the growing demand for
Cellectricon’s transfection systems, SCiSOURCE will serve the North American
Life Science market, representing Cellectricon and its Cellaxess® products.
Following the recent milestone order for Cellaxess®HT, the world’s first high throughput RNAi
screening System, Cellectricon reinforces its commitment to expanding its North American
business. SCiSOURCE will sell and promote the Cellaxess® products and further expand
Cellectricon’s presence in the United States and Canada.